Back to Dashboard








Johnson & Johnson (JNJ)
Real-time intraday values
Market Overview
From:
To:
JNJ Intraday
No data available
SymbolJNJ
IPO DateJan 2, 1962
CEOMr. Joaquin Duato
Full Time Employees138.2k
SectorHealthcare
IndustryDrug Manufacturers - General
CountryUnited States
ExchangeNYSE
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Performance
| Period | Return % | Value Change |
|---|---|---|
| 1 Day | -1.41% | -3.77 US$ |
| 5 Days | +3.24% | +8.28 US$ |
| 1 Month | -1.98% | -5.33 US$ |
| 6 Months | +15.97% | +36.34 US$ |
Analyzing Market with AI
Evaluating the last 30 days of history and fundamental metrics of JNJ...
Key Statistics
Market Cap
635.07B
P/E Ratio
40.03
Div Yield
2.03%
52W High
$281.07
52W Low
$184.66
Analyst Consensus
ConsensusBuy
Bullish1669.6%
Neutral626.1%
Bearish14.3%
52W Analyst Price Targets
Min Target
$190.00
$190.00
Max Target
$320.00
$320.00
Current$263.84
Avg Target$279.41
Analyst Recommendations
Target Price:$279.41($190.00 - $320.00)
Community Thoughts
Share your analysis and sentiment on JNJ
Join the community to share your analysis
Latest News for JNJ

Smith & Nephew (LSE:SN.) Stays Independent, Is It 8% Undervalued?
Simply Wall St.•Oct 25, 2026, 04:05 PM


Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule
PR Newswire•Oct 25, 2026, 07:30 AM

Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy?
Motley Fool•Oct 24, 2026, 04:31 PM

J&J’s Smith & Nephew Deal Collapsed Over One Executive. Here’s What It Means for the DePuy Spin
TIKR•Oct 24, 2026, 07:38 AM

Arrowhead Pharmaceuticals And 2 Biotech Stocks To Own
Simply Wall St.•Oct 24, 2026, 02:09 AM
Sector Update: Healthcare Stocks Fall Late Afternoon
MT Newswires•Oct 23, 2026, 07:56 PM
Sector Update: Healthcare Stocks Decline Friday Afternoon
MT Newswires•Oct 23, 2026, 05:51 PM
Smith And Nephew Merger Talks With Johnson & Johnson Collapse Over Leadership Dispute
TIKR•Oct 23, 2026, 05:06 PM